BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 1582798)

  • 1. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
    Seregard S; Spångberg B; Juul C; Oskarsson M
    Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
    Moshari A; McLean IW
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple cytologic method for predicting the malignant potential of intraocular melanoma.
    Huntington A; Haugan P; Gamel J; McLean I
    Pathol Res Pract; 1989 Nov; 185(5):631-4. PubMed ID: 2696944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases.
    Al-Jamal RT; Toivonen P; Kivelä T
    Acta Ophthalmol; 2010 Jun; 88(4):458-62. PubMed ID: 19549104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of morphometric features and the callender classification in uveal melanomas.
    Coleman K; Baak JP; van Diest PJ; Mullaney J
    Ophthalmology; 1996 Oct; 103(10):1634-41. PubMed ID: 8874437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas.
    Kujala E; Toivonen P
    Eye (Lond); 2006 Jan; 20(1):123-4; author reply 124-5. PubMed ID: 15688050
    [No Abstract]   [Full Text] [Related]  

  • 11. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups.
    Augsburger JJ; Gamel JW; Shields JA
    Trans Am Ophthalmol Soc; 1989; 87():348-59; discussion 359-61. PubMed ID: 2562523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
    Libman ES; Brovkina AF; Bezrukov AV
    Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
    Seregard S; Oskarsson M; Spångberg B
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal-ciliary body melanoma. A multivariate survival analysis of tumor location.
    McLean IW; Ainbinder DJ; Gamel JW; McCurdy JB
    Ophthalmology; 1995 Jul; 102(7):1060-4. PubMed ID: 9121753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective assessment of the malignant potential of intraocular melanomas with standard microslides stained with hematoxylin-eosin.
    Gamel JW; McLean I; Greenberg RA; Naids RM; Folberg R; Donoso LA; Seddon JM; Albert DM
    Hum Pathol; 1985 Jul; 16(7):689-92. PubMed ID: 2408986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal melanoma: the importance of large nucleoli in predicting patient outcome--an automated image analysis study.
    McLean IW; Sibug ME; Becker RL; McCurdy JB
    Cancer; 1997 Mar; 79(5):982-8. PubMed ID: 9041161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
    Kujala E; Kivelä T
    Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.